MetaCap

Korro Bio Statistics

NASDAQ: KRROHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.18-0.01 (-0.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Korro Bio by the numbers

Korro Bio has a market capitalization of $167.2 million based on 13.73M shares outstanding. With trailing EPS of $-8.89, Korro Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.4% above its 50-day average and 0.1% above its 200-day average.

Average daily trading volume is 186.03K shares, or about $2.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KRRO valuation vs. peer median

KRRO compared with the median of 8 peer companies
MetricKRROPeer medianDifference
Market cap$167.18M$171.38M-2%
Avg. volume186.03K287.27K-35%

Peer median across 8 companies: ABEO, TRDA, EMIS, SIGA, VOGX, NATR, ORMP, ADCT.

Valuation

Market cap
$167.18M
Price / sales (latest FY)
26.15
EPS (TTM)
$-8.89

Price and trading

Previous close
12.19
Open
12.03
Day range
12.01 – 12.95
52-week range
5.20 – 17.35
52-week change
+93.95%
Beta
—
Volume
123.52K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
167.18M
Forward Pe
-2.85
Eps
-8.89
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.35
Week52 Low
5.20
Avg Volume
186.03K
Shares Outstanding
13.73M
Ma50
11.78
Ma200
12.16
Earnings Date
Nov 5, 2026
Pct From52w High
-29.81%
Pct From52w Low
134.05%

Related